Topics
Oligodendroglioma | Overall management | Overview
Home > Publications > Topics > Oligodendroglioma > Overall management > Overview
Sasaki H, Kitamura Y, Toda M, Hirose Y, Yoshida
K.
Oligodendroglioma, IDH-mutant and
1p/19q-codeleted-prognostic factors, standard of care and
chemotherapy, and future perspectives with neoadjuvant
strategy.
Brain
Tumor Pathol. 2024 Apr 2. doi:
10.1007/s10014-024-00480-1. PMID:
38564040. Review˰ ˍ
Jiang K, Kalluri A, Odonkor M, Heinemann DM, Weber-Levine C, Raj
D, Materi J, Rakovec M, Pineda E, Redmond KJ, Romo C, Kamson DO,
Holdhoff M, Schreck KC, González Sánchez JJ,
Bettegowda C, Rincon-Torroella J.
Trends
in the Management of
Oligodendrogliomas: A Multinational and Multidisciplinary Survey
Study.
World Neurosurg. 2025 Feb 11:123716? doi:
10.1016/j.wneu.2025.123716? PMID:
39947316. Observational study˰
ˍ